Researchers: COVID Clinical Trials Lack Diversity

In the Adaptive COVID-19 Treatment Trial involving more than 1,000 patients testing the efficacy of the antiviral remdesivir, only 20% of participants are Black and 23% are Hispanic or Native American.

from WebMD Health https://ift.tt/2CAWvxj